In this issue:
Rivaroxaban in patients with AF and bioprosthetic mitral valves
Natriuretic peptides for detection of diastolic dysfunction and HFpEF
Long-term efficacy and safety of drug-coated balloons vs DES
Redevelopment and validation of the SYNTAX score II
Outcomes after STEMI presentation to hospitals in NZ
Disappointing findings for omega-3 fatty acids in high-risk patients
Relevance of changes in hs-cTnI levels after exercise stress testing
Beta-blockers in patients with COPD and cardiovascular disease
A decade of transcatheter aortic valve implantation in NZ
Prophylactic scaffolding of vulnerable coronary atherosclerotic lesions
Please login below to download this issue (PDF)